4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-051214
Chief Medical Officer sold 10,000 shares at $100.00 ($1,000,000)
- Chief Medical Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Detke Michael J. · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-10 | Exercise or conversion : show line 1 in the form | +10,000 | $2.23 | $22,300 | 10,000 | D |
| 2021-08-10 | Sale : show line 2 in the form | −10,000 | $100.00 | $1,000,000 | 0 | D |
| Open-market sales · 10,000 sh · avg $100.00 · $1,000,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-10 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −10,000 | 92,352 | D |
Loading xslF345X03/doc4.xml…